Antiprotozoal Malaria Box compounds with activity in biological assays and lacking toxicity at therapeutic levels.

C. Van Voorhis Wesley, Fidock David A., Dang Na Le, Bickle Quentin, Roberto Adelfio(Swiss Tropical and Public Health Institute), Noemi Cowan(Swiss Tropical and Public Health Institute), Marian Brennan(Royal College of Surgeons in Ireland), Chubb Anthony, Burton Audrey(Scynexis (United States)), Boyom Fabrice F., Manuela Carrasquilla(Pennsylvania State University), Joseph L. DeRisi(University of California, San Francisco), Lotfi Bounaadja(Sorbonne Université), Avery Vicky M., Alday Aintzane(Diputación Foral de Gipuzkoa), Tana Bowling(Scynexis (United States)), Grazia Camarda(Istituto Superiore di Sanità), Myles H. Akabas(Albert Einstein College of Medicine), Ayong Lawrence, D’Alessandro Sarah, José Brea(Universidade de Santiago de Compostela), Yolanda Corbett(University of Milan), Gregory J. Crowther(University of Washington), Ahyong Vida, Delves Michael, Michael T. Ferdig(University of Notre Dame), Sandra Duffy(Griffith University), Ainhoa Alzualde(Biogipuzkoa Health Research Institute), Chindaudomsate Worathad(Mahidol University), Caffrey Conor R., Alan Y. Du(University of California San Diego), Jürgen Bosch(Johns Hopkins University), Katherine T. Andrews(Griffith University), Bhatia Sangeeta, Simon V. Avery(University of Nottingham), Alano Pietro, Alsibaee Aishah, Beatrice L. Colon(University of South Florida), Mark Baker(Novartis (Switzerland)), Carter Dee
INDIGO (University of Illinois at Chicago)
July 29, 2016
Cited by 0


Related Papers